Gregory Ryslik is a statistician, data scientist and artificial intelligence researcher with experience building and leading data initiatives in companies across the biotech, autotech, healthtech and fintech domains. Most recently, Greg Ryslik was the Chief Data Officer at Celsius Therapeutics in Cambridge, MA, a biotechnology company focused on single cell RNA sequencing. Prior to that, he was Vice President of Data Science at Mindstrong Health, a healthcare company transforming mental health treatment through measurement science and artificial intelligence. Greg has also spent time in the automotive sector, first at Tesla Motors, leading the Service Data Science group in Palo Alto, CA and then as the Head and Senior Director of Data Science at Faraday Future in Los Angeles, CA. Earlier in his career, he performed machine learning research and nonclinical biostatistics research at Genentech and was an actuary in New York City at PricewaterhouseCoopers.

Greg lectures on statistics for artificial intelligence and machine learning at Stanford Continuing Studies and is an Assistant Professor of Practice at The Ohio State University. He is also a fellow of the Casualty Actuarial Society, as well as a member of the American Academy of Actuaries. His research has been published in journals ranging from Nature to BMC Bioinformatics and has led to several software packages on mutational clustering. Greg holds a PhD from Yale University in biostatistics, a master’s degree in statistics from Columbia University and an undergraduate degree in mathematics, computer science and finance from Rutgers University.